AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionDeDora Capital, Inc.
Latest Disclosed Ownership14,699 shares
Latest Disclosed Value $ 3,196,805
DeDora Capital, Inc. reports 1.06% decrease in ownership of 4AB / AbbVie Inc.

On April 27, 2026 - DeDora Capital, Inc. filed a 13F-HR form disclosing ownership of 14,699 shares of AbbVie Inc. (BG:4AB) valued at $3,196,805 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 14,856 shares of AbbVie Inc.. This represents a change in shares of -1.06% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ABBVIE COM 00287Y109 14,699 -157 -1.06 3,197 -5.83 0.7838
2026-01-22 2025-12-31 13F ABBVIE COM 00287Y109 14,856 -398 -2.61 3,394 -3.88 0.8035
2025-10-29 2025-09-30 13F ABBVIE COM 00287Y109 15,254 -495 -3.14 3,532 20.80 0.8525
2025-07-29 2025-06-30 13F ABBVIE COM 00287Y109 15,749 -162 -1.02 2,923 -12.30 0.7631
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 15,911 -206 -1.28 3,334 16.38 0.9608
2025-01-30 2024-12-31 13F ABBVIE COM 00287Y109 16,117 -63 -0.39 2,864 -10.36 0.7843
2024-10-21 2024-09-30 13F ABBVIE COM 00287Y109 16,180 -61 -0.38 3,195 14.72 0.8926
2024-07-17 2024-06-30 13F ABBVIE COM 00287Y109 16,241 283 1.77 2,786 -4.13 0.8557
2024-04-23 2024-03-31 13F/A-1 ABBVIE COM 00287Y109 15,958 -2,174 -11.99 2,906 3.42 0.9251
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 15,958 -2,174 2,906 0.9268
2024-01-18 2023-12-31 13F ABBVIE COM 00287Y109 18,132 -674 -3.58 2,810 0.21 0.9863
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 18,806 898 5.01 2,803 16.21 1.1040
2023-07-24 2023-06-30 13F ABBVIE COM 00287Y109 17,908 677 3.93 2,413 -12.16 0.9351
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 17,231 1,603 10.26 2,746 8.75 1.1717
2023-01-19 2022-12-31 13F ABBVIE COM 00287Y109 15,628 38 0.24 2,526 20.70 1.1990
2022-10-14 2022-09-30 13F ABBVIE COM 00287Y109 15,590 68 0.44 2,092 -11.99 1.0886
2022-07-27 2022-06-30 13F ABBVIE COM 00287Y109 15,522 -1,038 -6.27 2,377 -11.44 1.1975
2022-04-14 2022-03-31 13F ABBVIE COM 00287Y109 16,560 16,560 2,684 1.0849
2022-01-15 2021-12-31 13F ABBVIE COM 00287Y109 0 -16,636 -100.00 0 -100.00
2021-10-18 2021-09-30 13F ABBVIE COM 00287Y109 16,636 142 0.86 1,795 -3.39 0.7803
2021-08-03 2021-06-30 13F ABBVIE COM 00287Y109 16,494 260 1.60 1,858 5.75 0.8099
2021-04-27 2021-03-31 13F ABBVIE COM 00287Y109 16,234 -1,348 -7.67 1,757 -6.74 0.8314
2021-01-29 2020-12-31 13F ABBVIE COM 00287Y109 17,582 -1,728 -8.95 1,884 11.41 0.9297
2020-10-20 2020-09-30 13F ABBVIE COM 00287Y109 19,310 3,186 19.76 1,691 6.82 0.9443
2020-07-31 2020-06-30 13F ABBVIE COM 00287Y109 16,124 748 4.86 1,583 35.18 0.9546
2020-05-04 2020-03-31 13F ABBVIE COM 00287Y109 15,376 107 0.70 1,171 -13.39 0.8837
2020-02-21 2019-12-31 13F ABBVIE COM 00287Y109 15,269 -816 -5.07 1,352 11.00 0.8142
2019-10-22 2019-09-30 13F ABBVIE COM 00287Y109 16,085 -5,943 -26.98 1,218 -23.97 0.8430
2019-08-08 2019-06-30 13F/A-1 ABBVIE COM 00287Y109 22,028 -6,250 -22.10 1,602 -29.71 1.1274
2019-07-24 2019-06-30 13F ABBVIE COM 00287Y109 28,278 0 2,279
2019-04-12 2019-03-31 13F ABBVIE COM 00287Y109 28,278 3,153 12.55 2,279 -1.60 1.7188
2019-01-18 2018-12-31 13F ABBVIE COM 00287Y109 25,125 395 1.60 2,316 -0.98 2.0500
2018-10-19 2018-09-30 13F ABBVIE COM 00287Y109 24,730 4,000 19.30 2,339 21.76 1.7715
2018-07-31 2018-06-30 13F ABBVIE COM 00287Y109 20,730 76 0.37 1,921 -1.74 1.5133
2018-04-16 2018-03-31 13F ABBVIE COM 00287Y109 20,654 2,415 13.24 1,955 10.83 1.5894
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 18,239 18,239 1,764 1.4609
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.